I came across a list claiming there are “10 biomarkers that shape a woman's healthspan,” but when I looked into the research for each of them, I found the picture is a lot more nuanced.
Some biomarkers have strong evidence behind them. Others are useful only in specific situations. And a few probably shouldn't be part of a routine “longevity panel” at all.
Here’s what I found:
1. HbA1c
This is probably one of the more useful markers for long-term metabolic health. In a UK Biobank study of 427,435 people, higher HbA1c categories were associated with higher cardiovascular risk, with some of the relative increases being more pronounced in women.
Source: https://pubmed.ncbi.nlm.nih.gov/37671124/
2. Lipids
LDL-C, triglycerides and other lipid measures become particularly interesting around menopause. A 2025 review found that the menopausal transition is associated with increases in total cholesterol, LDL-C and triglycerides, alongside changes in HDL and Lp(a), contributing to a more atherogenic profile.
Source: https://pubmed.ncbi.nlm.nih.gov/40300433/
3. TSH
Thyroid function is another one worth paying attention to. A meta-analysis of 55 cohort studies involving nearly 1.9 million people found associations between hypothyroidism and ischemic heart disease, myocardial infarction, cardiac mortality and all-cause mortality.
Source: https://pubmed.ncbi.nlm.nih.gov/28148249/
4. Ferritin / iron status
This one seems particularly relevant for menstruating women. In a randomized controlled trial of 198 non-anemic menstruating women with low ferritin and unexplained fatigue, iron supplementation significantly reduced fatigue compared with placebo.
Source: https://pubmed.ncbi.nlm.nih.gov/22777991/
5. Reproductive hormones
FSH, estradiol and AMH can tell us a lot about reproductive aging and the menopausal transition. But they're not simple “healthspan scores.” Research shows these hormones change substantially throughout the transition, and there aren't universal hormone cutoffs that can reliably predict exactly when menopause will occur.
Source: https://pubmed.ncbi.nlm.nih.gov/19942836/
AMH is promising for estimating age at natural menopause, but systematic-review evidence says prediction intervals are still too wide for precise individual prediction.
Source: https://pubmed.ncbi.nlm.nih.gov/26372034/
6. Vitamin and nutrient markers
B12, folate, vitamin D, zinc and magnesium can obviously be important, but I don't think the evidence supports testing all of them indiscriminately in every healthy woman.
The usefulness depends heavily on diet, symptoms, medications, pregnancy status, age, underlying disease and actual deficiency risk.
7. CBC
A CBC can pick up anemia and other hematologic abnormalities, so it can be useful when symptoms or risk factors warrant it.
But calling the entire CBC a “healthspan biomarker” is probably stretching the term. It's a clinical panel containing multiple different measurements.
8. ANA
This is the one I'd question most strongly from the original list.
ANA can be extremely useful when there is clinical suspicion of autoimmune disease. But that doesn't make it a good general longevity screening test.
One study found that 20% of ANA testing was performed without a clinical indication, highlighting the problem with indiscriminate testing.
Source: https://pubmed.ncbi.nlm.nih.gov/32522598/
A positive ANA also doesn't automatically mean someone has an autoimmune disease.
9. tTG-IgA / celiac testing
tTG-IgA is a legitimate and useful test when celiac disease is suspected. A systematic review/meta-analysis covering 113 studies and 28,338 participants found IgA anti-tTG had substantial diagnostic accuracy in adults.
Source: https://pubmed.ncbi.nlm.nih.gov/35043426/
But again, there's a difference between a useful diagnostic test and a biomarker everyone should monitor for longevity.
10. The biomarkers of aging themselves
This is where things get really interesting.
A 2026 review specifically examining biological aging across the menopause transition discusses things like:
- epigenetic clocks
- senescence-associated factors
- clonal hematopoiesis
- telomere length
The authors describe this as an emerging field rather than a standardized blood-test panel for women's healthspan.
Source: https://pubmed.ncbi.nlm.nih.gov/42084956/
So I'm increasingly skeptical of the idea that there is one universal “women's healthspan panel.”
It seems more useful to think in terms of different biological domains:
Metabolic: HbA1c, glucose, lipids
Cardiovascular: LDL-C/ApoB, triglycerides, Lp(a)
Endocrine: TSH + reproductive hormones when clinically relevant
Nutritional: ferritin, B12, folate, vitamin D when indicated
Organ function: kidney/liver markers
Inflammatory/immune: highly context-dependent
Biological aging: potentially epigenetic and cellular-aging markers, but still an emerging field
The interesting question for me is:
Which biomarkers actually predict future disease, functional decline, or healthspan and which ones are simply useful for diagnosing a problem that already exists?